---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-003205"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T09:01:37.291311+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "low"
source: SEC EDGAR
---

# Silexion posts updated corporate presentation for H.C. Wainwright conference

## Summary
- Updated corporate presentation posted to company website on September 2, 2025.
- Presentation to be presented on September 10, 2025 at H.C. Wainwright Global Investment Conference in New York.
- No specific financial or clinical data disclosed in the 8-K filing excerpt.

## SEC filing metadata
- accession: 0001178913-25-003205
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/0001178913-25-003205-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325003205/zk2533739.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-003205
- JSON: https://secwatch.observer/filing/0001178913-25-003205.json
- Plain text: https://secwatch.observer/filing/0001178913-25-003205.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.